Case StudiesCase series evaluation: ACTISORB Silver 220 in practice

Case series evaluation: ACTISORB Silver 220 in practice

Supplements

Case series evaluation: ACTISORB Silver 220 in practiceACTISORB Silver 220 may be useful in managing malodour and bacterial burden and the associated signs in a variety of wounds, including friable/overgranulated tissue, percutaneous endoscopic gastronomy tubes, malignant/palliative wounds, necrotic toes and fungal infection.

This case series evaluation shows the wide range of wounds for which the combination of activated charcoal and metallic silver can achieve treatment goals including elimination of infection, control of malodour and progress towards healing. Supported by Systagenix